%0 Generic
%T Association between molecular subtype membership or hypoxia-associated gene expression signatures and clinical outcomes in the CALGB 90601 (Alliance) phase 3 clinical trial of gemcitabine and cisplatin (GC) plus bevacizumab (B) or placebo (P).
%A McConkey, David James
%A Choi, Woonyoung
%A Halabi, Susan
%A Luo, Bin
%A Al-Ahmadie, Hikmat A.
%A Rosenberg, Jonathan E.
%A Mountain, Jack
%A Regazzi, Ashley Marie
%A Fong, Megan
%A Iyer, Gopa
%A Van Allen, Eliezer Mendel
%A Mouw, Kent William
%A Wen, Yujia
%A McCart, Linda
%A Ballman, Karla V.
%A Beltran, Himisha
%A Morris, Michael J.
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2022
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation